Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

CHARLOTTESVILLE, Va. (WVIR) -A new study led by UVA Health is changing how doctors may treat sepsis in parts of Africa, after ...

Analysis of finger sweat detected isoniazid in adults with tuberculosis (TB) for ≤ 6 hours after administration, based on data from a new pilot study. Risk factors for TB treatment failure include ...

The bacteria that cause tuberculosis harbor some natural resistance to fluoroquinolones, but biophysicists from Johns Hopkins in Baltimore may have discovered why that is and how to make the ...

Blood infection, medically known as sepsis, is one of the leading causes of death, because the body’s response to infection damages tissue and causes organs to fail. Africa has the ...

A medication developed in the 1950s to treat Parkinson's disease may offer a powerful new tool in the fight against tuberculosis (TB), according to new research from the University of British Columbia ...

A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...